Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Herbal extracts to prevent gastric disease in hospitalized burn patients
IRCT20200128046288N2Phase 3Completed
- Sponsor
- Ahvaz Jundishapur University of Medical Sciences
- Start
- Jun 2020
- Countries
- 1
01
Overview
Phase 3 trial of phyllanthus emblica extract in gastroesophageal reflux disease (GERD) and Peptic ulcer disease (PUD), sponsored by Ahvaz Jundishapur University of Medical Sciences. Started Jun 2020; status: completed.
02
Drugs
phyllanthus emblica extract
03
Conditions
gastroesophageal reflux disease (GERD)Peptic ulcer disease (PUD)
Beyond the preview
Go deeper on IRCT20200128046288N2.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on IRCT20200128046288N2.